Strategies to reduce muscle loss in aging women
Official title: Muscle Mass, Quality, and the Menopause: Sex-specific Strategies to Mitigate Sarcopenia in Ageing Populations
Run by University of Nottingham · NCT06806501 · Data updated 2026-11-12
This study looks at how aging and menopause affect muscle loss in women aged 18-65 who don’t exercise regularly, to find ways to help them maintain muscle and stay healthy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 18 (estimated) |
| Sponsor | University of Nottingham Academic / other |
| Locations | 1 site (Nottingham) |
| Status | Recruiting |
| Started | July 29, 2024 |
| Main results expected | March 2026 |
| Study ends | March 2026 |
| Registry record updated | February 4, 2025 |
| Trial ID | NCT06806501 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are biological women aged 18-65 with a BMI between 18-30 who do not perform regular resistance exercise.
✕Probably not a fit
Patients with significant cardiovascular, respiratory, or metabolic diseases, or those with a BMI outside the specified range, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the impact of aging on muscle mass and function, particularly focusing on the differences between men and women. It aims to understand how menopause affects muscle loss and physical disability in women aged 18-65 who do not regularly engage in resistance exercise. The study will explore the relationship between body composition changes, such as increased fat infiltration into muscle, and the development of sarcopenia. By identifying sex-specific strategies, the research seeks to mitigate the effects of sarcopenia and improve health outcomes for aging populations.
Why it matters
Potential benefit: If successful, this study could lead to targeted interventions that improve muscle health and reduce frailty in aging women.
How similar studies have gone: While there is ongoing research into sarcopenia and its effects, this study's specific focus on sex differences and menopause-related muscle loss is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological woman, 18-65 years of age * Body mass index (BMI) 18-30 kg/m2 * Non smoker * Not performing regular resistance type exercise * Participant is willing and able to give informed consent for participation in the study Exclusion Criteria: * A BMI \<18 or \>39 kg·m-2 * Active cardiovascular disease: uncontrolled hypertension (Blood pressure \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt or recent cardiac event. * Cerebrovascular disease: previous stroke, aneurysm (large vessel or intracranial) * Respiratory disease including pulmonary hypertension or Chronic obstructive pulmonary disease (COPD). * Metabolic disease: hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, types 1 or 2 diabetes (treated and untreated), polycystic ovarian syndrome (PCOS), inborn/ congenital errors of metabolism (e.g. Phenylketonuria (PKU), galactosaemia) * Active inflammatory bowel disease. * Acute infection. * Acute or chronic renal disease. * Malignancy (or history of malignancy with 5 y). * Recent (within 6 mo) or current steroid treatment, hormone replacement therapy (HRT), hormonal contraception, or other hormonal therapies that may interfere with outcome measures. * Coagulopathy. * Musculoskeletal or neurological disorders. * Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance. * Amenorrhoea for a reason other than menopause. * Contraindications for Magnetic Resonance Imaging (MRI). * Allergy or sensitivity to local anaesthesia, or dressing adhesive. * Inner ear pathology or vertigo
Where it's running
-
Queens Medical Centre Campus
Nottingham, United Kingdom Recruiting
Study contacts
- Study coordinator: Matthew Brook
- Email: Matthew.Brook@nottingham.ac.uk
- Phone: 0115 8230248
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.